首页> 外文学位 >Regulation of endothelial cell apoptosis by Vascular Endothelial Growth Inhibitor (VEGI) and death receptor 3 (DR3).
【24h】

Regulation of endothelial cell apoptosis by Vascular Endothelial Growth Inhibitor (VEGI) and death receptor 3 (DR3).

机译:血管内皮生长抑制剂(VEGI)和死亡受体3(DR3)对内皮细胞凋亡的调节。

获取原文
获取原文并翻译 | 示例

摘要

Vascular Endothelial Growth Inhibitor (VEGI) is an endothelial cell autocrine factor and a member of the tumor necrosis family of ligands. VEGI is able to specifically inhibit endothelial cell growth and is an efficient inhibitor of angiogenesis. The molecular mechanisms of VEGI activity on endothelial cells remain undefined. Here we focused on two important steps in the signal transduction of VEGI. We first determined a role of NF-kappaB in VEGI-induced apoptosis. We found that inhibition of the NF-kappaB pathway resulted in an increased apoptotic potential of VEGI. We conclude that the NF-kappaB pathway plays a role in suppressing the apoptotic potential of VEGI. We next investigated the receptor responsible for VEGI-induced endothelial cell apoptosis. DR3 is a receptor for VEGI and thus we first focused on confirming if DR3 is the receptor responsible for VEGI-mediated endothelial cell death. We determined VEGI had diminished apoptotic activity in endothelial cells that are depleted of DR3 by siRNA. However, it was determined that the apoptotic stimuli, LPS and TNFalpha, were also unable to mediate cell death in DR3-depleted endothelial cells. We conclude that DR3 is mediating an intracellular event that is involved in controlling the apoptotic pathway. This is a novel role of DR3 that is yet to be described. However, this role of DR3 interferes with our analysis of the ligand/receptor relationship and therefore we were unable to confirm that DR3 is the receptor responsible for VEGI-induced apoptosis. We also provide preliminary evidence that VEGI is utilizing an unknown receptor to mediate NF-kappaB activation. We therefore provide several mechanisms to control VEGI-mediated endothelial cell death, one being the activation of NF-kappaB to suppress the apoptotic potential of VEGI and the needed presence of DR3 for VEGI to initiate apoptosis, a role that is possibly independent of ligand binding.
机译:血管内皮生长抑制剂(VEGI)是内皮细胞自分泌因子,是肿瘤坏死配体家族的成员。 VEGI能够特异性抑制内皮细胞生长,并且是血管生成的有效抑制剂。 VEGI活性对内皮细胞的分子机制仍然不确定。在这里,我们专注于VEGI信号转导的两个重要步骤。我们首先确定了NF-κB在VEGI诱导的细胞凋亡中的作用。我们发现抑制NF-κB通路导致VEGI的凋亡潜力增加。我们得出结论,NF-κB通路在抑制VEGI的凋亡潜力中发挥作用。接下来,我们研究了负责VEGI诱导的内皮细胞凋亡的受体。 DR3是VEGI的受体,因此我们首先关注于确定DR3是否为VEGI介导的内皮细胞死亡的受体。我们确定VEGI已减少了siRNA耗尽DR3的内皮细胞的凋亡活性。然而,已确定凋亡的刺激物LPS和TNFalpha也不能介导DR3耗尽的内皮细胞中的细胞死亡。我们得出结论,DR3正在介导参与控制细胞凋亡途径的细胞内事件。这是DR3的新颖角色,尚待描述。但是,DR3的这种作用干扰了我们对配体/受体关系的分析,因此我们无法确认DR3是负责VEGI诱导的细胞凋亡的受体。我们还提供了初步证据,证明VEGI正在利用未知受体介导NF-κB活化。因此,我们提供了几种控制VEGI介导的内皮细胞死亡的机制,一种是激活NF-κB以抑制VEGI的凋亡潜能,以及DR3的存在以促进VEGI启动细胞凋亡,这一作用可能与配体结合无关。

著录项

  • 作者

    Grimaldo, Sammy R.;

  • 作者单位

    University of Pittsburgh.;

  • 授予单位 University of Pittsburgh.;
  • 学科 Biology Cell.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 117 p.
  • 总页数 117
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

  • 入库时间 2022-08-17 11:39:00

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号